Skip to main content
SpringerLink
Log in

Altered Pharmacology and Pill Burden in Older Adults: A Balancing Act

  • Chapter
  • First Online:
Dialysis in Older Adults

  • 785 Accesses

Abstract

Older adults represent one of the fasting growing age groups in many countries including the United States [1]. This rate of growth is mirrored in the dialysis population. The number of incident dialysis patients over the age of 65 years is greater than 50 %. The number of incident dialysis patients greater than 75 years of age represents the fasting growing population of dialysis patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Department of Health & Human Services AoA. U.S. Population by Age: July 1, 2010; 2010 [updated July 1 2010; cited 2014 1 Jul]

    Google Scholar 

  2. Chiu YW, Teitelbaum I, Misra M, de Leon EM, Adzize T, Mehrotra R (2009) Pill burden, adherence, hyperphosphatemia, and quality of life in maintenance dialysis patients. Clin J Am Soc Nephrol CJASN 4(6):1089–1096

    Article  PubMed  Google Scholar 

  3. Lassiter J, Bennett WM, Olyaei AJ (2013) Drug dosing in elderly patients with chronic kidney disease. Clin Geriatr Med 29(3):657–705

    Article  PubMed  Google Scholar 

  4. Olyaei AJ, Bennett WM (2009) Drug dosing in the elderly patients with chronic kidney disease. Clin Geriatr Med 25(3):459–527

    Article  PubMed  Google Scholar 

  5. Rolita L, Freedman M (2008) Over-the-counter medication use in older adults. J Gerontol Nurs 34(4):8–17

    Article  PubMed  Google Scholar 

  6. Larsen PD, Martin JL (1999) Polypharmacy and elderly patients. AORN J 69(3):619–622, 25, 27–28

    Article  CAS  PubMed  Google Scholar 

  7. Hubbard RE, O’Mahony MS, Woodhouse KW (2013) Medication prescribing in frail older people. Eur J Clin Pharmacol 69(3):319–326

    Article  PubMed  Google Scholar 

  8. Rifkin DE, Laws MB, Rao M, Balakrishnan VS, Sarnak MJ, Wilson IB (2010) Medication adherence behavior and priorities among older adults with CKD: a semistructured interview study. Am J Kidney Dis Off J National Kidney Found 56(3):439–446

    Article  Google Scholar 

  9. Pai AB, Cardone KE, Manley HJ, St Peter WL, Shaffer R, Somers M et al (2013) Medication reconciliation and therapy management in dialysis-dependent patients: need for a systematic approach. Clin J Am Soc Nephrol CJASN 8(11):1988–1999

    Article  PubMed  Google Scholar 

  10. Hammerlein A, Derendorf H, Lowenthal DT (1998) Pharmacokinetic and pharmacodynamic changes in the elderly. Clinical implications. Clin Pharmacokinet 35(1):49–64

    Article  CAS  PubMed  Google Scholar 

  11. Bender AD (1968) Effect of age on intestinal absorption: implications for drug absorption in the elderly. J Am Geriatr Soc 16(12):1331–1339

    Article  CAS  PubMed  Google Scholar 

  12. Van Vlem B, Schoonjans R, Vanholder R, De Vos M, Vandamme W, Van Laecke S et al (2000) Delayed gastric emptying in dyspeptic chronic hemodialysis patients. Am J Kidney Dis Off J National Kidney Found 36(5):962–968

    Article  Google Scholar 

  13. Van V, Schoonjans RS, Struijk DG, Verbanck JJ, Vanholder RC, Van B et al (2002) Influence of dialysate on gastric emptying time in peritoneal dialysis patients. Perit Dial Int J Int Soc Perit Dial 22(1):32–38

    Google Scholar 

  14. Joy MS, Frye RF, Nolin TD, Roberts BV, La MK, Wang J et al (2014) In vivo alterations in drug metabolism and transport pathways in patients with chronic kidney diseases. Pharmacotherapy 34(2):114–122

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Naud J, Nolin TD, Leblond FA, Pichette V (2012) Current understanding of drug disposition in kidney disease. J Clin Pharmacol 52(1 Suppl):10s–22s

    Article  CAS  PubMed  Google Scholar 

  16. Schmucker DL (2005) Age-related changes in liver structure and function: Implications for disease? Exp Gerontol 40(8–9):650–659

    Article  CAS  PubMed  Google Scholar 

  17. Schmucker DL (1985) Aging and drug disposition: an update. Pharmacol Rev 37(2):133–148

    CAS  PubMed  Google Scholar 

  18. Nolin TD, Frye RF, Le P, Sadr H, Naud J, Leblond FA et al (2009) ESRD impairs nonrenal clearance of fexofenadine but not midazolam. J Am Soc Nephrol JASN 20(10):2269–2276

    Article  CAS  PubMed  Google Scholar 

  19. Fleg JL, Schulman S, O’Connor F, Becker LC, Gerstenblith G, Clulow JF et al (1994) Effects of acute beta-adrenergic receptor blockade on age-associated changes in cardiovascular performance during dynamic exercise. Circulation 90(5):2333–2341

    Article  CAS  PubMed  Google Scholar 

  20. Fleg JL, Strait J (2012) Age-associated changes in cardiovascular structure and function: a fertile milieu for future disease. Heart Fail Rev 17(4–5):545–554

    Article  PubMed  PubMed Central  Google Scholar 

  21. White M, Roden R, Minobe W, Khan MF, Larrabee P, Wollmering M et al (1994) Age-related changes in beta-adrenergic neuroeffector systems in the human heart. Circulation 90(3):1225–1238

    Article  CAS  PubMed  Google Scholar 

  22. Newgard CB, Pessin JE (2014) Recent progress in metabolic signaling pathways regulating aging and life span. J Gerontol A Biol Sci Med Sci 69(Suppl 1):S21–S27

    Article  PubMed  PubMed Central  Google Scholar 

  23. Bowie MW, Slattum PW (2007) Pharmacodynamics in older adults: a review. Am J Geriatr Pharmacother 5(3):263–303

    Article  CAS  PubMed  Google Scholar 

  24. Andros E, Detmar-Hanna D, Suteparuk S, Gal J, Gerber JG (1996) The effect of aging on the pharmacokinetics and pharmacodynamics of prazosin. Eur J Clin Pharmacol 50(1–2):41–46

    Article  CAS  PubMed  Google Scholar 

  25. Peters R (2006) Ageing and the brain. Postgrad Med J 82(964):84–88

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Dardano A, Penno G, Del Prato S, Miccoli R (2014) Optimal therapy of type 2 diabetes: a controversial challenge. Aging 6(3):187–206

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Diaz-Buxo JA (2000) Use of intraperitoneal insulin with CCPD. Semin Dial 13(3):207

    Article  CAS  PubMed  Google Scholar 

  28. Nevalainen PI, Lahtela JT, Mustonen J, Taskinen MR, Pasternack A (1999) The effect of insulin delivery route on lipoproteins in type I diabetic patients on CAPD. Perit Dial Int J Int Soc Perit Dial 19(2):148–153

    CAS  Google Scholar 

  29. Quellhorst E (2002) Insulin therapy during peritoneal dialysis: pros and cons of various forms of administration. J Am Soc Nephrol JASN 13(Suppl 1):S92–S96

    CAS  PubMed  Google Scholar 

  30. Torun D, Oguzkurt L, Sezer S, Zumrutdal A, Singan M, Adam FU et al (2005) Hepatic subcapsular steatosis as a complication associated with intraperitoneal insulin treatment in diabetic peritoneal dialysis patients. Perit Dial Int J Int Soc Perit Dial 25(6):596–600

    Google Scholar 

  31. Chan KE, Lazarus JM, Hakim RM (2010) Digoxin associates with mortality in ESRD. J Am Soc Nephrol JASN 21(9):1550–1559

    Article  CAS  PubMed  Google Scholar 

  32. Dager WE, Kiser TH (2010) Systemic anticoagulation considerations in chronic kidney disease. Adv Chronic Kidney Dis 17(5):420–427

    Article  PubMed  Google Scholar 

  33. Santoro D, Satta E, Messina S, Costantino G, Savica V, Bellinghieri G (2013) Pain in end-stage renal disease: a frequent and neglected clinical problem. Clin Nephrol 79(Suppl 1):S2–S11

    PubMed  Google Scholar 

  34. Pasticci F, Fantuzzi AL, Pegoraro M, McCann M, Bedogni G (2012) Nutritional management of stage 5 chronic kidney disease. J Ren Care 38(1):50–58

    Article  PubMed  Google Scholar 

  35. Andres E, Serraj K, Federici L, Vogel T, Kaltenbach G (2013) Anemia in elderly patients: new insight into an old disorder. Geriatr Gerontol Int 13(3):519–527

    Article  PubMed  Google Scholar 

  36. Andro M, Le Squere P, Estivin S, Gentric A (2013) Anaemia and cognitive performances in the elderly: a systematic review. Eur J Neurol Off J Eur Fed Neurol Soc 20(9):1234–1240

    CAS  Google Scholar 

  37. American Geriatrics Society Beers Criteria Update Expert Panel (2012) American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 60(4):616–631

    Article  Google Scholar 

  38. Gallagher P, O’Mahony D (2008) STOPP (Screening Tool of Older Persons’ potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers’ criteria. Age Ageing 37(6):673–679

    Article  PubMed  Google Scholar 

  39. Hamilton H, Gallagher P, Ryan C, Byrne S, O’Mahony D (2011) Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients. Arch Intern Med 171(11):1013–1019

    Article  PubMed  Google Scholar 

  40. Desrochers JF, Lemieux JP, Morin-Belanger C, Paradis FS, Lord A, Bell R et al (2011) Development and validation of the PAIR (Pharmacotherapy Assessment in Chronic Renal Disease) criteria to assess medication safety and use issues in patients with CKD. Am J Kidney Dis Off J National Kidney Found 58(4):527–535

    Article  Google Scholar 

  41. Manley HJ, Drayer DK, McClaran M, Bender W, Muther RS (2003) Drug record discrepancies in an outpatient electronic medical record: frequency, type, and potential impact on patient care at a hemodialysis center. Pharmacotherapy 23(2):231–239

    Article  PubMed  Google Scholar 

  42. George J, Phun YT, Bailey MJ, Kong DC, Stewart K (2004) Development and validation of the medication regimen complexity index. Ann Pharmacother 38(9):1369–1376

    Article  PubMed  Google Scholar 

  43. Browne T, Merighi JR (2010) Barriers to adult hemodialysis patients’ self-management of oral medications. Am J Kidney Dis Off J National Kidney Found 56(3):547–557

    Article  Google Scholar 

  44. Lee DS, de Rekeneire N, Hanlon JT, Gill TM, Bauer DC, Meibohm B et al (2012) Cognitive impairment and medication complexity in community-living older adults: the health, aging and body composition study. J Pharm Technol JPT Off Publ Assoc Pharm Tech 28(4):156–162

    CAS  Google Scholar 

  45. Power A, Brown E (2013) Optimising treatment of end-stage renal disease in the elderly. Nephron Clin Pract 124(3–4):202–208

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacy Practice, Albany College of Pharmacy and Health Sciences, Albany, NY, USA

    Darren W. Grabe PharmD & Katie E. Cardone PharmD, BCACP

Authors
  1. Darren W. Grabe PharmD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Katie E. Cardone PharmD, BCACP
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Darren W. Grabe PharmD .

Editor information

Editors and Affiliations

  1. University of Missouri Columbia, Div of Nephrology Department of Medicine, Columbia, Missouri, USA

    Madhukar Misra

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media New York

About this chapter

Cite this chapter

Grabe, D.W., Cardone, K.E. (2016). Altered Pharmacology and Pill Burden in Older Adults: A Balancing Act. In: Misra, M. (eds) Dialysis in Older Adults. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-3320-4_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-3320-4_11

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-3318-1

  • Online ISBN: 978-1-4939-3320-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation